The McMaster University Medical Centre is a major Ontario hospital with three key services: McMaster Children's Hospital, Women's Health Centre and Adult Outpatient Services. It is a teaching hospital in Hamilton, Ontario, Canada. It is a part of McMaster University, but operated by Hamilton Health Sciences.

There are 365 beds in McMaster University Medical Centre.

During the past decade, McMaster University Medical Centre conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 33 clinical trials were completed, i.e. on average, 40.2% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 19 clinical trials were completed. i.e. 61.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McMaster University Medical Centre" #1 sponsor was "McMaster University" with 30 trials, followed by "Hamilton Health Sciences Corporation" with 20 trials sponsored, "Pfizer" with 9 trials sponsored, "Cytokinetics" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McMaster University Medical Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 23 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 5 trials as a collaborator, "The Physicians' Services Incorporated Foundation" with 4 trials as a collaborator, "Canadian Critical Care Trials Group" with 3 trials as a collaborator and "Gilead Sciences" with 3 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "McMaster University Medical Centre" are "HIV Infections" (12 trials), "Ulcerative Colitis" (11 trials), "Irritable Bowel Syndrome" (7 trials), "Amyotrophic Lateral Sclerosis" (6 trials) and "Asthma" (6 trials). Many other conditions were trialed in "McMaster University Medical Centre" in a lesser frequency.

Most popular intervention types in "McMaster University Medical Centre" are "Drug" (88 trials), "Other" (30 trials), "Biological" (17 trials), "Behavioral" (7 trials) and "Dietary Supplement" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Filgotinib" (4 trials), "placebo" (4 trials), "AR101" (3 trials) and "AT2221" (2 trials). Other intervention names were less common.

The vast majority of trials in "McMaster University Medical Centre" are 138 trials for "All" genders, 11 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 29 active trials in "McMaster University Medical Centre". 2 are not yet recruiting, 18 are recruiting, 6 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 99 completed trials in McMaster University Medical Centre, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in McMaster University Medical Centre, 5 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".